Hollsteen
← Corning

Revenue by segment/product/region: Life Sciences

Flow – sum over the period · $M

QuartersFiscal years

$MRevenue by segment/product/region: Life Sciences · Q1 2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Revenue by segment/product/region: Life Sciences · Q2 2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Revenue by segment/product/region: Life Sciences · Q3 2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Revenue by segment/product/region: Life Sciences · Q4 2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Revenue by segment/product/region: Life Sciences · Q1 2017: $210M · 10-Q 0000024741-18-000018 filed Apr 26, 2018Revenue by segment/product/region: Life Sciences · Q2 2017: $221M · 10-Q 0000024741-18-000045 filed Jul 27, 2018Revenue by segment/product/region: Life Sciences · Q3 2017: $223M · 10-Q 0000024741-18-000053 filed Oct 24, 2018Revenue by segment/product/region: Life Sciences · Q4 2017: $225M · derived · 10-K 0000024741-19-000016 filed Feb 12, 2019Revenue by segment/product/region: Life Sciences · Q1 2018: $232M · 10-Q 0000024741-18-000018 filed Apr 26, 2018Revenue by segment/product/region: Life Sciences · Q2 2018: $245M · 10-Q 0000024741-18-000045 filed Jul 27, 2018Revenue by segment/product/region: Life Sciences · Q3 2018: $231M · 10-Q 0000024741-18-000053 filed Oct 24, 2018Revenue by segment/product/region: Life Sciences · Q4 2018: $238M · derived · 10-K 0000024741-19-000016 filed Feb 12, 2019Revenue by segment/product/region: Life Sciences · Q1 2019: $243M · 10-Q 0000024741-19-000026 filed May 3, 2019Revenue by segment/product/region: Life Sciences · Q2 2019: $260M · 10-Q 0000024741-19-000052 filed Jul 31, 2019Revenue by segment/product/region: Life Sciences · Q3 2019: $256M · 10-Q 0000024741-19-000061 filed Oct 30, 2019Revenue by segment/product/region: Life Sciences · Q4 2019: missing – No verified SEC value extracted, although the company reports this metric in other periods.Revenue by segment/product/region: Life Sciences · Q1 2020: not reported – Segment/product 'glw:LifeSciencesMember' is reported in the SEC XBRL data only for FY2016–FY2019 (segment structure changed).Revenue by segment/product/region: Life Sciences · Q2 2020: not reported – Segment/product 'glw:LifeSciencesMember' is reported in the SEC XBRL data only for FY2016–FY2019 (segment structure changed).Revenue by segment/product/region: Life Sciences · Q3 2020: not reported – Segment/product 'glw:LifeSciencesMember' is reported in the SEC XBRL data only for FY2016–FY2019 (segment structure changed).Revenue by segment/product/region: Life Sciences · Q4 2020: not reported – Segment/product 'glw:LifeSciencesMember' is reported in the SEC XBRL data only for FY2016–FY2019 (segment structure changed).Revenue by segment/product/region: Life Sciences · Q1 2021: not reported – Segment/product 'glw:LifeSciencesMember' is reported in the SEC XBRL data only for FY2016–FY2019 (segment structure changed).Revenue by segment/product/region: Life Sciences · Q2 2021: not reported – Segment/product 'glw:LifeSciencesMember' is reported in the SEC XBRL data only for FY2016–FY2019 (segment structure changed).Revenue by segment/product/region: Life Sciences · Q3 2021: not reported – Segment/product 'glw:LifeSciencesMember' is reported in the SEC XBRL data only for FY2016–FY2019 (segment structure changed).Revenue by segment/product/region: Life Sciences · Q4 2021: not reported – Segment/product 'glw:LifeSciencesMember' is reported in the SEC XBRL data only for FY2016–FY2019 (segment structure changed).Revenue by segment/product/region: Life Sciences · Q1 2022: not reported – Segment/product 'glw:LifeSciencesMember' is reported in the SEC XBRL data only for FY2016–FY2019 (segment structure changed).Revenue by segment/product/region: Life Sciences · Q2 2022: not reported – Segment/product 'glw:LifeSciencesMember' is reported in the SEC XBRL data only for FY2016–FY2019 (segment structure changed).Revenue by segment/product/region: Life Sciences · Q3 2022: not reported – Segment/product 'glw:LifeSciencesMember' is reported in the SEC XBRL data only for FY2016–FY2019 (segment structure changed).Revenue by segment/product/region: Life Sciences · Q4 2022: not reported – Segment/product 'glw:LifeSciencesMember' is reported in the SEC XBRL data only for FY2016–FY2019 (segment structure changed).Revenue by segment/product/region: Life Sciences · Q1 2023: not reported – Segment/product 'glw:LifeSciencesMember' is reported in the SEC XBRL data only for FY2016–FY2019 (segment structure changed).Revenue by segment/product/region: Life Sciences · Q2 2023: not reported – Segment/product 'glw:LifeSciencesMember' is reported in the SEC XBRL data only for FY2016–FY2019 (segment structure changed).Revenue by segment/product/region: Life Sciences · Q3 2023: not reported – Segment/product 'glw:LifeSciencesMember' is reported in the SEC XBRL data only for FY2016–FY2019 (segment structure changed).Revenue by segment/product/region: Life Sciences · Q4 2023: not reported – Segment/product 'glw:LifeSciencesMember' is reported in the SEC XBRL data only for FY2016–FY2019 (segment structure changed).Revenue by segment/product/region: Life Sciences · Q1 2024: not reported – Segment/product 'glw:LifeSciencesMember' is reported in the SEC XBRL data only for FY2016–FY2019 (segment structure changed).Revenue by segment/product/region: Life Sciences · Q2 2024: not reported – Segment/product 'glw:LifeSciencesMember' is reported in the SEC XBRL data only for FY2016–FY2019 (segment structure changed).Revenue by segment/product/region: Life Sciences · Q3 2024: not reported – Segment/product 'glw:LifeSciencesMember' is reported in the SEC XBRL data only for FY2016–FY2019 (segment structure changed).Revenue by segment/product/region: Life Sciences · Q4 2024: not reported – Segment/product 'glw:LifeSciencesMember' is reported in the SEC XBRL data only for FY2016–FY2019 (segment structure changed).Revenue by segment/product/region: Life Sciences · Q1 2025: not reported – Segment/product 'glw:LifeSciencesMember' is reported in the SEC XBRL data only for FY2016–FY2019 (segment structure changed).Revenue by segment/product/region: Life Sciences · Q2 2025: not reported – Segment/product 'glw:LifeSciencesMember' is reported in the SEC XBRL data only for FY2016–FY2019 (segment structure changed).Revenue by segment/product/region: Life Sciences · Q3 2025: not reported – Segment/product 'glw:LifeSciencesMember' is reported in the SEC XBRL data only for FY2016–FY2019 (segment structure changed).Revenue by segment/product/region: Life Sciences · Q4 2025: not reported – Segment/product 'glw:LifeSciencesMember' is reported in the SEC XBRL data only for FY2016–FY2019 (segment structure changed).Revenue by segment/product/region: Life Sciences · Q1 2026: not reported – Segment/product 'glw:LifeSciencesMember' is reported in the SEC XBRL data only for FY2016–FY2019 (segment structure changed).Revenue by segment/product/region: Life Sciences · Q2 2026: not reported – Segment/product 'glw:LifeSciencesMember' is reported in the SEC XBRL data only for FY2016–FY2019 (segment structure changed).not reported256210Q1 2016Q2 2026Q3 2019
Q3 2019
256$M
All values (11)
PeriodValue ($M)Status
Q3 2019256reported
Q2 2019260reported
Q1 2019243reported
Q4 2018238derived
Q3 2018231reported
Q2 2018245reported
Q1 2018232reported
Q4 2017225derived
Q3 2017223reported
Q2 2017221reported
Q1 2017210reported

31 periods without value hidden · Show gaps with reason · CSV with all sources · Technical ID: seg_revenue / glw:LifeSciencesMember

More metrics for Corning
Sources & calculation
Value
$256M
Period
Q3 2019, ended Sep 30, 2019 · quarterly value (3 months, not cumulative)
Source
10-Q, filed Oct 30, 2019 · 0000024741-19-000061
Location
us-gaap:Revenues [us-gaap:StatementBusinessSegmentsAxis=glw:LifeSciencesMember]
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$256MOct 30, 201910-Q 0000024741-19-000061reported · confidence 1. · current